Tag

publications – access to medicines
March 1, 2022ByIn

Position paper: The revision of the Orphan Medicinal Products Regulation

ECL-EFPN-Reflection-paper-on-the-revision-of-OMP-regulation_final
Continue Reading
February 1, 2022ByIn

Motion for a European Parliament resolution on a pharmaceutical strategy for Europe 

INI-Pharmaceutical_Strategy_for_Europe_amendements_ECL_A2MTF
Continue Reading
December 1, 2021ByIn

Infographic: ECL recommendations for the revision of the Pharmaceutical Legislation 

ECL-Attachment-pharmaceutical-legislation-consultation_final
Continue Reading
December 1, 2021ByIn

Report: Cross-border collaboration initiatives in the healthcare space 

ECL-Cross-Border-Initiatives-Paper
Continue Reading
July 23, 2021ByIn

Infographic: 4 ways towards successful European cooperation on HTA 

HTA-ECL-Position-infographic-1
Continue Reading
June 8, 2021ByIn,

Bridging efforts to tackle medicine shortages at the EU level

Continue Reading
June 1, 2021ByIn

Joint recommendations: The Health Technology Assessment 

ECL-Anticancer-Fund-policy-document_HTA-and-its-final-steps_13062021
Continue Reading
May 1, 2021ByIn

Civil society recommendations for improving the Orphan and Paediatric Regulations 

Joint_Recommendations_Paediatric_Orphan_Policy-dialogue_200521
Continue Reading
May 1, 2021ByIn

ECL’s contribution to the 2021 WHO Fair Pricing Forum 

2021-Fair-Pricing-Forum_ECL_contribution
Continue Reading
September 1, 2020ByIn

Support of Aspen Pharma commitments on excessive pricing  

ECL_Aspen-Commitments_comment-16092020
Continue Reading
1 2 3 4 5